Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep;140(3):764-767.
doi: 10.1378/chest.11-0710.

The role of the clinical and translational science awards program in improving the quality and efficiency of clinical research

Affiliations

The role of the clinical and translational science awards program in improving the quality and efficiency of clinical research

Daniel Rosenblum et al. Chest. 2011 Sep.

Abstract

Recognizing the need to increase the efficiency and quality of translating basic discovery into treatment and prevention strategies for patients and the public, the National Institutes of Health (NIH) announced the Clinical and Translational Science Awards (CTSAs) in 2006. Academic health centers that competed successfully for these awards agreed to work as a consortium and in cooperation with the NIH to improve the translation process by training the next generation of investigators to work in interdisciplinary teams, developing public-private partnerships in the movement of basic discovery to preclinical and clinical studies and trials, improving clinical research management, and engaging with communities to ensure their involvement in shaping research questions and in implementing research results. The CTSAs have addressed the crucial need to improve the quality and efficiency of clinical research by (1) providing training for clinical investigators and for bench researchers to facilitate their participation in the clinical and translational research environment, (2) developing more systematic approaches to clinical research management, and (3) engaging communities as active participants in the design and conduct of clinical research studies and trials and as leaders in implementing health advances that are of high importance to them. We provide an overview of the CTSA activities with attention to these three areas, which are essential to developing efficient clinical research efforts and effective implementation of research results on a national level.

PubMed Disclaimer

References

    1. Dilts DM, Sandler AB. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. J Clin Oncol. 2006;24(28):4545–4552. - PubMed
    1. Dilts DM, Cheng SK, Crites JS, Sandler AB, Doroshow JH. Phase III clinical trial development: a process of chutes and ladders. Clin Cancer Res. 2010;16(22):5381–5389. - PMC - PubMed
    1. Grady C. Do IRBs protect human research participants? JAMA. 2010;304(10):1122–1123. - PubMed
    1. Millum J, Menikoff J. Streamlining ethical review. Ann Intern Med. 2010;153(10):655–657. - PMC - PubMed
    1. Mah E, Bierer B, Cobb N, Johnson T, Hirschfeld S Secretary’s Advisory Committee on Human Research Protections (SACHRP) Meeting Presentations. US Department of Health and Human Services Web site. http://www.hhs.gov/ohrp/sachrp/.Published October 19-20,2010.Accessed March 14, 2011.

MeSH terms